U.S. Markets closed

EnteroMedics Inc. (ETRM)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.91-0.02 (-1.04%)
At close: 4:00PM EDT
People also watch
IDXGPULMBIOCXGTIGLBS
  • H
    HotPicks
    HotPicks

    SNOA (MC $23 M) (Cash $13 M) Shares Out: 4.3 M /Undiscovered Stock/ Lots of Marketed Products some of them are in early launch phase plus additional Product launches expected within 6 months / Profitable in 2018 = 1000%+ UPSIDE POTENTIAL..Please do your own dd and realize the Monster Potential here .Thank me later

    Sonoma Pharma (Nasdaq: SNOA)

    Market Cap: 22.1 Million
    Cash: $12.6 Million
    Price: $5.15

    Shares Out : 4.3 Million

    Presentation
    http://ir.sonomapharma.com/common/download/download.cfm?companyid=ocls&fileid=945547&filekey=F57B6874-6CD1-4205-A160-8E08BBB7A928&filename=SonomaPharma_Investor_presentation_13June2017.pdf

    Fact Sheet
    http://files.shareholder.com/downloads/OCLS/4977255852x0x231236/39d834a3-8462-40ee-8650-e0945b6facd5/Sonoma_Fact_Sheet.pdf

    Driving to commercial EBITDAS breakeven, without dilution

    Grow current product portfolio with all sales people

    •Alevicyn HydroGel, Dermal Spray & Spray Gel for atopic dermatitis & dermal procedures •Celacyn for scar treatment
    •Mondoxyne for severe acne –launched late 2015
    •Ceramax for skin repair in atopic dermatitis–launched in April 2016
    •SebuDerm for seborrhea dermatitis –launched in November 2016

    Launch 3 New Products –our product pipeline –one every other quarter

    •Launching Loyon–Fall 2017
    •Ceramax in foam and gel forms –Q4 2017 & Q1 2018

    Launch and Grow New and Current Products: During fiscal year 2017, we launched four new dermatology products, including SebuDerm™, Ceramax™, Lasercyn™ Gel and Lasercyn™ Dermal Spray, bringing us to a total of eight dermatology products for the treatment of atopic and seborrheic dermatitis, scar management, surgical procedures, severe acne and “state of the art” skin repair technology. We also obtained three new FDA clearances, now totaling 16 overall. Our strong intellectual property portfolio consists of 63 issued patents and 33 patent applications pending.

    We plan to launch our new FDA approved product Loyon® (a skin descaler currently marketed in Europe) in the upcoming months and have a strong product pipeline of several product line improvements, including a line extension of Ceramax™. All in all, we believe this could possibly be our best product line of new FDA approved dermatology and skincare products yet, and we believe our innovation plan will help lead us to profitability.

  • J
    Justin
    Justin
    I remember when this was at $1 and it shot up to $30, I got in at $7 and sold at $28.
  • N
    Nicholas
    Nicholas
    If you have shares before the reverse split, what are they worth now?
  • N
    Nicholas
    Nicholas
    Not looking good.
  • J
    Jim
    Jim
    This stock is going to shoot up, very strong buy right now.
  • V
    Vincent
    Vincent
    They must need money bad to wreck the share price even below the conversion price.
  • Y
    Yong
    Yong
    Great great performance for this stock!!
  • A
    AmericaOwnsChuck
    AmericaOwnsChuck
    Who can I sue?
  • N
    Nicholas
    Nicholas
    At least employees and management will still get paid
  • N
    Nicholas
    Nicholas
    All I can say about the conference call is a bunch of FLUFF !! I do support anything that can help veterans. I would only own stock for that reason.
  • b
    blue
    blue
    HERE COMES THESCARY SCARY CRASH CRASHBELOW $1.50 YOU WATCH AND SEE TOLD TOLD YOU THIS WILL CRASH CRASHBELOW $1.50 BE VERY VERY AFRAID TO LOSS ALOT LOT MORE MONEY
  • P
    Pete
    Pete
    Now here is a great buying opportunity.
  • T
    Tron II
    Tron II
    JEezze guys, I'm sorry for the drop. Check out OXIS, about to run hard to make your money back. Cancer drugs and new management from Pfizer and Chase Pharma. Do your dd.
  • E
    Emil
    Emil
    Just heard there have been 5 deaths that were attributed to the Gastric Balloon implants. This is unfortunate for the victims, but may present an opportunity for ETRM to drive their message home and promote their non anatomy-altering solution to deal with obesity.
  • W
    WILKIN
    WILKIN
    Go up so i cam short tomorrow.
  • k
    knoxville Superman
    knoxville Superman
    this company and product goes nowhere without insurance coverage. maybe this will get them there.
  • b
    blue
    blue
    NO NEED TO HOLD THIS ANYMORE MASSESEMASSESE SELLING COMING CRASHINGBELOW $1.50 BEVERY VERY AFRAID TO LOSS ALOTLOT MORE MONEY BEVERYVERY AFRAID GET OUT BEFORE EVERYONE START TO SELL AND DUMP DUMP THIER SHARES BELOW $1.50
  • a
    all in
    all in
    all in @ $2
  • d
    dave
    dave
    ANOTHER DOGSHEET LOSER POS COMPANY THAT HAS A PRODUCT NO ONE WANTS.........HERE COMES $0 SOON!
  • v
    veno
    veno
    This company is like Mankind. Both have great products to offer but they don't. Nobody knows about them but there investors.Why aren't we seeing advertising and marketing of any kind? what a waste! I think they are a sham/scam...